Pulmonary aspergillosis and mucormycosis in a patient with COVID-19
Andre K. Johnson, Zeron Ghazarian, Kristina D. Cendrowski, Jon Persichino
Abstract
Invasive pulmonary mucormycosis and aspergillosis are rare, life-threatening fungal infections. Most documented cases have been reported in patients with diabetes mellitus, neutropenia, or treatment with corticosteroids. Both infections have been recognized as secondary complications of COVID-19, especially among critically ill patients. We report the first case of combined probable pulmonary aspergillosis and possible mucormycosis in a male with COVID-19 in the ICU.
Topics & Concepts
MucormycosisMedicineAspergillosisNeutropeniaCoronavirus disease 2019 (COVID-19)VoriconazolePulmonary aspergillosisDermatologyDiabetes mellitusMycosisImmunosuppressionIntensive care medicineInfectious disease (medical specialty)Internal medicineAntifungalImmunologyPathologyDiseaseChemotherapyEndocrinologyAntifungal resistance and susceptibilityFungal Infections and StudiesPneumocystis jirovecii pneumonia detection and treatment